Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease barrett esophagus
Comorbidity C0017168|gastroesophageal reflux
Sentences 10
PubMedID- 21636532 gastroesophageal reflux is associated with adenocarcinoma in barrett's esophagus, but the incidence of this tumor is rising, despite widespread use of acid-suppressing medications.
PubMedID- 23663216 The need for obstructive sleep apnea screening in barrett's esophagus patients with nocturnal gastroesophageal reflux symptoms should be further evaluated.
PubMedID- 20086178 gastroesophageal reflux disease complicated by barrett's esophagus (be) is a major risk factor for esophageal adenocarcinoma (ea).
PubMedID- 25632808 Adiponectin may modify the risk of barrett's esophagus in patients with gastroesophageal reflux disease.
PubMedID- 20946664 Background: esophageal adenocarcinomas (eacs) arise due to gastroesophageal reflux, with barrett's esophagus (be) regarded as precancerous lesion.
PubMedID- 21694467 Background: esophageal adenocarcinomas (eacs) arise due to gastroesophageal reflux, with barrett's esophagus (be) regarded as precancerous lesion.
PubMedID- 23504527 barrett's esophagus, with gastroesophageal reflux disease and obesity as risk factors, predisposes to esophageal adenocarcinoma (eac).
PubMedID- 26032153 Control of acid and duodenogastroesophageal reflux (dger) in patients with barrett's esophagus.
PubMedID- 25804032 [prospects for improving the management tactics for patients with gastroesophageal reflux disease complicated by barrett's esophagus].
PubMedID- 26377193 A newly identified susceptibility locus near foxp1 modifies the association of gastroesophageal reflux with barrett's esophagus.

Page: 1